Home > Healthcare & Medical Devices > Isothermal Nucleic Acid Amplification Technology (INAAT) Market > Table of Contents

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size By Technology (Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification (NASBA), Helicase-dependent Amplification (HDA)), By Product (Instruments, Reagents), By Application, (Infectious Disease {HIV, Influenza, Malaria, Tuberculosis}, Oncology, Blood Screening), By End-use (Hospitals, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI5251
  • Published Date: Apr 2022
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Isothermal Nucleic Acid Amplification Technology (INAAT) testing industry 360° synopsis, 2017 - 2028

2.1.1    Business trends

2.1.2    Technology trends

2.1.3    Products trends

2.1.4    Application trends

2.1.5    End-use trends

2.1.6    Regional trends

Chapter 3   Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2028

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Rising prevalence of infectious diseases

3.3.1.2    Increasing adoption of INAAT over PCR

3.3.1.3    Increasing blood transfusion

3.3.1.4    Rise in demand for low-cost and effective diagnostics procedures

3.3.1.5    Technological advancements to boost market growth

3.3.2    Industry pitfalls & challenges

3.3.2.1    Lack of awareness about new diagnostics technologies

3.3.2.2    Opposition from PCR technologies will pose a major challenge

3.4    Growth potential analysis

3.4.1    By technology

3.4.2    By product

3.4.3    By application

3.4.4    By end-use

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2021

3.7.1    Company matrix analysis, 2021

3.8    PESTEL analysis

Chapter 4   Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology

4.1    Key segment trends

4.2    Loop-mediated Isothermal Amplification (LAMP)

4.2.1    Market size, by region, 2017 - 2028 (USD Million)

4.3    Strand Displacement Amplification (SDA)

4.3.1    Market size, by region, 2017 - 2028 (USD Million)

4.4    Nucleic Acid Sequence-based Amplification (NASBA)

4.4.1    Market size, by region, 2017 - 2028 (USD Million)

4.5    Helicase-dependent Amplification (HDA)

4.5.1    Market size, by region, 2017 - 2028 (USD Million)

4.6    Others

4.6.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 5   Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product

5.1    Key segment trends

5.2    Instruments

5.2.1    Market size, by region, 2017 - 2028 (USD Million)

5.3    Reagents

5.3.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 6   Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application

6.1    Key segment trends

6.2    Infectious disease

6.2.1    Market size, by region, 2017 - 2028 (USD Million)

6.2.2    HIV

6.2.2.1    Market size, by region, 2017 - 2028 (USD Million)

6.2.3    Influenza

6.2.3.1    Market size, by region, 2017 - 2028 (USD Million)

6.2.4    Malaria

6.2.4.1    Market size, by region, 2017 - 2028 (USD Million)

6.2.5    Tuberculosis

6.2.5.1    Market size, by region, 2017 - 2028 (USD Million)

6.3    Oncology

6.3.1    Market size, by region, 2017 - 2028 (USD Million)

6.4    Blood Screening

6.4.1    Market size, by region, 2017 - 2028 (USD Million)

6.5    Others

6.5.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 7   Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End-use

7.1    Key segment trends

7.2    Hospitals

7.2.1    Market size, by region, 2017 - 2028 (USD Million)

7.3    Diagnostic Laboratories

7.3.1    Market size, by region, 2017 - 2028 (USD Million)

7.4    Others

7.4.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 8   Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country, 2017 - 2028 (USD Million)

8.2.2    Market size, by technology, 2017 - 2028 (USD Million)

8.2.3    Market size, by product, 2017 - 2028 (USD Million)

8.2.4    Market size, by application, 2017 - 2028 (USD Million)

8.2.4.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.2.5    Market size, by end-use, 2017 - 2028 (USD Million)

8.2.6    U.S.

8.2.6.1    Market size, by technology, 2017 - 2028 (USD Million)

8.2.6.2    Market size, by product, 2017 - 2028 (USD Million)

8.2.6.3    Market size, by application, 2017 - 2028 (USD Million)

8.2.6.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.2.6.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.2.7    Canada

8.2.7.1    Market size, by technology, 2017 - 2028 (USD Million)

8.2.7.2    Market size, by product, 2017 - 2028 (USD Million)

8.2.7.3    Market size, by application, 2017 - 2028 (USD Million)

8.2.7.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.2.7.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.3    Europe

8.3.1    Market size, by country, 2017 - 2028 (USD Million)

8.3.2    Market size, by technology, 2017 - 2028 (USD Million)

8.3.3    Market size, by product, 2017 - 2028 (USD Million)

8.3.4    Market size, by application, 2017 - 2028 (USD Million)

8.3.4.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.3.5    Market size, by end-use, 2017 - 2028 (USD Million)

8.3.6    Germany

8.3.6.1    Market size, by technology, 2017 - 2028 (USD Million)

8.3.6.2    Market size, by product, 2017 - 2028 (USD Million)

8.3.6.3    Market size, by application, 2017 - 2028 (USD Million)

8.3.6.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.3.6.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.3.7    UK

8.3.7.1    Market size, by technology, 2017 - 2028 (USD Million)

8.3.7.2    Market size, by product, 2017 - 2028 (USD Million)

8.3.7.3    Market size, by application, 2017 - 2028 (USD Million)

8.3.7.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.3.7.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.3.8    France

8.3.8.1    Market size, by technology, 2017 - 2028 (USD Million)

8.3.8.2    Market size, by product, 2017 - 2028 (USD Million)

8.3.8.3    Market size, by application, 2017 - 2028 (USD Million)

8.3.8.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.3.8.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.3.9    Italy

8.3.9.1    Market size, by technology, 2017 - 2028 (USD Million)

8.3.9.2    Market size, by product, 2017 - 2028 (USD Million)

8.3.9.3    Market size, by application, 2017 - 2028 (USD Million)

8.3.9.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.3.9.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.3.10    Spain

8.3.10.1    Market size, by technology, 2017 - 2028 (USD Million)

8.3.10.2    Market size, by product, 2017 - 2028 (USD Million)

8.3.10.3    Market size, by application, 2017 - 2028 (USD Million)

8.3.10.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.3.10.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.4    Asia Pacific

8.4.1    Market size, by country, 2017 - 2028 (USD Million)

8.4.2    Market size, by technology, 2017 - 2028 (USD Million)

8.4.3    Market size, by product, 2017 - 2028 (USD Million)

8.4.4    Market size, by application, 2017 - 2028 (USD Million)

8.4.4.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.4.5    Market size, by end-use, 2017 - 2028 (USD Million)

8.4.6    China

8.4.6.1    Market size, by technology, 2017 - 2028 (USD Million)

8.4.6.2    Market size, by product, 2017 - 2028 (USD Million)

8.4.6.3    Market size, by application, 2017 - 2028 (USD Million)

8.4.6.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.4.6.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.4.7    Japan

8.4.7.1    Market size, by technology, 2017 - 2028 (USD Million)

8.4.7.2    Market size, by product, 2017 - 2028 (USD Million)

8.4.7.3    Market size, by application, 2017 - 2028 (USD Million)

8.4.7.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.4.7.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.4.8    India

8.4.8.1    Market size, by technology, 2017 - 2028 (USD Million)

8.4.8.2    Market size, by product, 2017 - 2028 (USD Million)

8.4.8.3    Market size, by application, 2017 - 2028 (USD Million)

8.4.8.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.4.8.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.4.9    Australia

8.4.9.1    Market size, by technology, 2017 - 2028 (USD Million)

8.4.9.2    Market size, by product, 2017 - 2028 (USD Million)

8.4.9.3    Market size, by application, 2017 - 2028 (USD Million)

8.4.9.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.4.9.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.5    Latin America

8.5.1    Market size, by country, 2017 - 2028 (USD Million)

8.5.2    Market size, by technology, 2017 - 2028 (USD Million)

8.5.3    Market size, by product, 2017 - 2028 (USD Million)

8.5.4    Market size, by application, 2017 - 2028 (USD Million)

8.5.4.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.5.5    Market size, by end-use, 2017 - 2028 (USD Million)

8.5.6    Brazil

8.5.6.1    Market size, by technology, 2017 - 2028 (USD Million)

8.5.6.2    Market size, by product, 2017 - 2028 (USD Million)

8.5.6.3    Market size, by application, 2017 - 2028 (USD Million)

8.5.6.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.5.6.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.5.7    Mexico

8.5.7.1    Market size, by technology, 2017 - 2028 (USD Million)

8.5.7.2    Market size, by product, 2017 - 2028 (USD Million)

8.5.7.3    Market size, by application, 2017 - 2028 (USD Million)

8.5.7.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.5.7.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.6    Middle East & Africa

8.6.1    Market size, by country, 2017 - 2028 (USD Million)

8.6.2    Market size, by technology, 2017 - 2028 (USD Million)

8.6.3    Market size, by product, 2017 - 2028 (USD Million)

8.6.4    Market size, by application, 2017 - 2028 (USD Million)

8.6.4.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.6.5    Market size, by end-use, 2017 - 2028 (USD Million)

8.6.6    Saudi Arabia

8.6.6.1    Market size, by technology, 2017 - 2028 (USD Million)

8.6.6.2    Market size, by product, 2017 - 2028 (USD Million)

8.6.6.3    Market size, by application, 2017 - 2028 (USD Million)

8.6.6.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.6.6.4    Market size, by end-use, 2017 - 2028 (USD Million)

8.6.7    South Africa

8.6.7.1    Market size, by technology, 2017 - 2028 (USD Million)

8.6.7.2    Market size, by product, 2017 - 2028 (USD Million)

8.6.7.3    Market size, by application, 2017 - 2028 (USD Million)

8.6.7.3.1    Market size, by infectious disease, 2017 - 2028 (USD Million)

8.6.7.4    Market size, by end-use, 2017 - 2028 (USD Million)

Chapter 9   Company Profiles

9.1    Competitive dashboard, 2021

9.2    Becton, Dickinson and Company

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    Abbott (Alere)

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.3.5    SWOT analysis

9.4    BioMerieux SA

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.4.5    SWOT analysis

9.5    Eiken Chemical Co. Ltd

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.5.5    SWOT analysis

9.6    Hologic Inc. (Gen-Probe)

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    Lucigen

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    SWOT analysis

9.8    Meridian Bioscience, Inc.

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.8.5    SWOT analysis

9.9    OptiGene Limited

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.9.5    SWOT analysis

9.10    Qiagen NV

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.10.5    SWOT analysis

9.11    Quidel Corporation

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.11.5    SWOT analysis

9.12    Tecan Genomics Inc.

9.12.1    Business overview

9.12.2    Financial data

9.12.3    Product landscape

9.12.4    Strategic outlook

9.12.5    SWOT analysis

9.13    Thermo Fisher Scientific Inc.

9.13.1    Business overview

9.13.2    Financial data

9.13.3    Product landscape

9.13.4    Strategic outlook

9.13.5    SWOT analysis

9.14    Ustar Biotechnologies Ltd.

9.14.1    Business overview

9.14.2    Financial data

9.14.3    Product landscape

9.14.4    Strategic outlook

9.14.5    SWOT analysis

9.15    Grifols, S.A.

9.15.1    Business overview

9.15.2    Financial data

9.15.3    Product landscape

9.15.4    Strategic outlook

9.15.5    SWOT analysis
 

Data Tables

TABLE 1    Isothermal nucleic acid amplification technology (INAAT) market, 2017 - 2021, (USD Million)

TABLE 2    Isothermal nucleic acid amplification technology (INAAT) market, 2022 - 2028, (USD Million)

TABLE 3    Isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 – 2021, (USD Million)

TABLE 4    Isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 – 2028, (USD Million)

TABLE 5    Isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 6    Isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 7    Isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 8    Isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 9    Isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 10    Isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 11    Isothermal nucleic acid amplification technology (INAAT) market by region, 2017 - 2021 (USD Million)

TABLE 12    Isothermal nucleic acid amplification technology (INAAT) market by region, 2022 - 2028 (USD Million)

TABLE 13    Industry impact forces

TABLE 14    Helicase-dependent amplification (HDA) market by region, 2017 – 2021 (USD Million)

TABLE 15    Helicase-dependent amplification (HDA) market by region, 2022 – 2028 (USD Million)

TABLE 16    Loop-mediated Isothermal Amplification (LAMP) market by region, 2017 – 2021 (USD Million)

TABLE 17    Loop-mediated Isothermal Amplification (LAMP) market by region, 2022 – 2028 (USD Million)

TABLE 18    Strand displacement amplification (SDA) market by region, 2017 – 2021 (USD Million)

TABLE 19    Strand displacement amplification (SDA) market by region, 2022 – 2028 (USD Million)

TABLE 20    Nucleic acid sequence-based amplification (NASBA) market by region, 2017 - 2021 (USD Million)

TABLE 21    Nucleic acid sequence-based amplification (NASBA) market by region, 2022 - 2028 (USD Million)

TABLE 22    Others market by region, 2017 – 2021 (USD Million)

TABLE 23    Others market by region, 2022 – 2028 (USD Million)

TABLE 24    Instruments market by region, 2017 – 2021 (USD Million)

TABLE 25    Instruments market by region, 2022 – 2028 (USD Million)

TABLE 26    Reagents market by region, 2017 – 2021 (USD Million)

TABLE 27    Reagents market by region, 2022 – 2028 (USD Million)

TABLE 28    Infectious disease market by region, 2017 – 2021 (USD Million)

TABLE 29    Infectious disease market by region, 2022 – 2028 (USD Million)

TABLE 30    Oncology market by region, 2017 – 2021 (USD Million)

TABLE 31    Oncology market by region, 2022 – 2028 (USD Million)

TABLE 32    Blood screening market by region, 2017 – 2021 (USD Million)

TABLE 33    Blood screening market by region, 2022 – 2028 (USD Million)

TABLE 34    Others market by region, 2017 – 2021 (USD Million)

TABLE 35    Others market by region, 2022 – 2028 (USD Million)

TABLE 36    North America isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)

TABLE 37    North America isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)

TABLE 38    North America isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 39    North America isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 40    North America isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 41    North America isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 42    North America isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 43    North America isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 44    North America isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 45    North America isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 46    North America isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 47    North America isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 48    U.S. isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 49    U.S. isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 50    U.S. isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 51    U.S. isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 52    U.S. isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 53    U.S. isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 54    U.S. isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 55    U.S. isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 56    U.S. isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 57    U.S. isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 58    Canada isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 59    Canada isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 60    Canada isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 61    Canada isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 62    Canada isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 63    Canada isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 64    Canada isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 65    Canada isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 66    Canada isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 67    Canada isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 68    Europe isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)

TABLE 69    Europe isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)

TABLE 70    Europe isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 71    Europe isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 72    Europe isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 73    Europe isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 74    Europe Isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 75    Europe isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 76    Europe isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 77    Europe isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 78    Europe isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 79    Europe isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 80    Germany isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 81    Germany isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 82    Germany isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 83    Germany isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 84    Germany isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 85    Germany isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 86    Germany isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 87    Germany isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 88    Germany isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 89    Germany isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 90    UK isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 91    UK isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 92    UK isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 93    UK isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 94    UK isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 95    UK isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 96    UK isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 97    UK isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 98    UK isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 99    UK isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 100    France isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 101    France isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 102    France isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 103    France isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 104    France isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 105    France isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 106    France isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 107    France isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 108    France isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 109    France isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 110    Spain isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 111    Spain isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 112    Spain isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 113    Spain isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 114    Spain isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 115    Spain isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 116    Spain isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 117    Spain isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 118    Spain isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 119    Spain isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 120    Italy isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 121    Italy isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 122    Italy isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 123    Italy isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 124    Italy isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 125    Italy isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 126    Italy isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 127    Italy isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 128    Italy isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 129    Italy isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 130    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)

TABLE 131    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)

TABLE 132    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 133    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 134    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 135    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 136    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 137    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 138    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 139    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 140    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 141    Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 142    Japan isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 143    Japan isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 144    Japan isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 145    Japan isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 146    Japan isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 147    Japan isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 148    Japan isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 149    Japan isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 150    Japan isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 151    Japan isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 152    China isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 153    China isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 154    China isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 155    China isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 156    China isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 157    China isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 158    China isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 159    China isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 160    China isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 161    China isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 162    India isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 163    India isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 164    India isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 165    India isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 166    India isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 167    India isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 168    India isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 169    India isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 170    India isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 171    India isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 172    Australia isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 173    Australia isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 174    Australia isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 175    Australia isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 176    Australia isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 177    Australia isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 178    Australia isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 179    Australia isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 180    Australia isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 181    Australia isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 182    Latin America isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)

TABLE 183    Latin America isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)

TABLE 184    Latin America isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 185    Latin America isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 186    Latin America isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 187    Latin America isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 188    Latin America isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 189    Latin America isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 190    Latin America isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 191    Latin America isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 192    Latin America isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 193    Latin America isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 194    Brazil isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 195    Brazil isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 196    Brazil isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 197    Brazil isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 198    Brazil isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 199    Brazil isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 200    Brazil isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 201    Brazil isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 202    Brazil isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 203    Brazil isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 204    Mexico isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 205    Mexico isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 206    Mexico isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 207    Mexico isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 208    Mexico isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 209    Mexico isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 210    Mexico isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 211    Mexico isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 212    Mexico isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 213    Mexico isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 214    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)

TABLE 215    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)

TABLE 216    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 217    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 218    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 219    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 220    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 221    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 222    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 223    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 224    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 225    Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 226    South Africa isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 227    South Africa isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 228    South Africa isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 229    South Africa isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 230    South Africa isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 231    South Africa isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 232    South Africa isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 233    South Africa isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 234    South Africa isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 235    South Africa isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

TABLE 236    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)

TABLE 237    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)

TABLE 238    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)

TABLE 239    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)

TABLE 240    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)

TABLE 241    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)

TABLE 242    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)

TABLE 243    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)

TABLE 244    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)

TABLE 245    Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)


Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Isothermal nucleic acid amplification technology (INAAT), 2017 - 2028 (USD Million)

FIG. 3    Growth potential analysis, by technology

FIG. 4    Growth potential analysis, by product

FIG. 5    Growth potential analysis, by application

FIG. 6    Growth potential analysis, by end-use

FIG. 7    Porter’s analysis

FIG. 8    PESTEL analysis

FIG. 9    Key segment trends, by technology

FIG. 10    Key segment trends, by product

FIG. 11    Key segment trends, by application

FIG. 12    Key segment trends, by end-use

FIG. 13    Key regional trends

FIG. 14    Competitive dashboard, 2021
 

Authors: Sumant Ugalmugle, Rupali Swain

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 14
  • Tables & Figures: 259
  • Countries covered: 15
  • Pages: 160

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount